thymoquinone has been researched along with Hepatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Amali, A; Danaei, GH; Karami, M; Khorrami, MB; Riahi-Zanjani, B; Sadeghi, M | 1 |
| Abd Al Haleem, EN; Awad, AS; El-Bakly, WM; Sherief, MA | 1 |
| Arikanoglu, Z; Evliyaoglu, O; Firat, U; Kapan, M; Onder, A; Taskesen, F; Tekin, R | 1 |
3 other study(ies) available for thymoquinone and Hepatitis
| Article | Year |
|---|---|
The significance of thymoquinone administration on liver toxicity of diazinon and cholinesterase activity; a recommendation for prophylaxis among individuals at risk.
Topics: Acetylcholinesterase; Alkaline Phosphatase; Animals; Antioxidants; Butyrylcholinesterase; Chemical and Drug Induced Liver Injury; Diazinon; Glutathione; Hepatitis; Organophosphorus Compounds; Pesticides; Rats; Superoxide Dismutase | 2022 |
Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Diet, High-Fat; Hepatitis; Inflammation Mediators; Insulin Resistance; Interleukin-10; Lipids; Liver; Liver Cirrhosis, Experimental; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Tumor Necrosis Factor-alpha | 2016 |
Thymoquinone ameliorates bacterial translocation and inflammatory response in rats with intestinal obstruction.
Topics: Animals; Anti-Bacterial Agents; Bacterial Translocation; Benzoquinones; Hepatitis; Histocytochemistry; Ileum; Inflammation; Intestinal Mucosa; Intestinal Obstruction; Lymph Nodes; Rats; Rats, Wistar; Statistics, Nonparametric | 2012 |